<DOC>
	<DOCNO>NCT01576003</DOCNO>
	<brief_summary>The purpose research study evaluate effect ( good bad ) supplementation Glutamine placebo ( L-alanine ) , child Short Bowel Syndrome . Researchers study see addition Glutamine oral/tube feeding ( nutrition therapy ) work well prevent bloodstream infection , improve growth , and/or change make-up bacteria child 's intestine . Glutamine approve FDA use adult Short Bowel Syndrome . In study , investigator assess well Glutamine affect Short Bowel Syndrome child .</brief_summary>
	<brief_title>Enteral Glutamine Reducing Bloodstream Infections Short Bowel Syndrome Infants</brief_title>
	<detailed_description>This double-blind , randomize placebo-controlled pilot study investigate efficacy enteral glutamine ( GLN ) supplementation 36 infant , â‰¤ 12 month age parenteral nutrition ( PN ) -dependent short bowel syndrome ( SBS ) due massive small bowel resection NEC and/or atresia improve wean PN prevent infection . The investigator intend evaluate effect enteral feeding GLN supplementation gut bacteria . The investigator also recruit 12 age-matched control evaluate normal gut bacteria .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Short Bowel Syndrome</mesh_term>
	<criteria>Inclusion Criteria Controls : Less equal 12 month age Normal small bowel length without intestinal resection primary intestinal disease Not currently TPN ever TPN discontinue least 4 week . Exclusion Criteria Controls : Major congenital chromosomal anomaly Inability tolerate enteral nutrition/regular cow 's milk , breast milk formula History liver/intestinal transplantation Inclusion Criteria Glutamine Placebo Group SBS Patients : Less equal 12 month age Patients undergone small bowel resection due NEC intestinal atresia know small bowel length Patients PN dependent 42 consecutive day currently TPN time enrollment Patients ability take partial enteral nutrition breast milk elemental formula allow appropriate dose glutamine placebo Signed informed consent use Glutamine placebo Exclusion Criteria Glutamine Placebo Group SBS Patients : Major congenital chromosomal anomaly Inability tolerate enteral nutrition preclude treatment enteral Glutamine Lalanine placebo &gt; 2 week Liver/Intestinal transplantation</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Short Bowel Syndrome</keyword>
	<keyword>Necrotizing Entercolitis ( NEC )</keyword>
	<keyword>Atresia</keyword>
	<keyword>Parenteral Nutrition</keyword>
	<keyword>Biological Markers</keyword>
	<keyword>Growth</keyword>
</DOC>